Dunbar, Hazel, Hawthorne, Ian J. and English, Karen (2024) Carbon monoxide licensing of MSCs enhances their efficacy through autophagy-mediated miRNA mechanisms. Molecular Therapy. ISSN 1525-0016
Preview
Available under License Creative Commons Attribution Non-commercial Share Alike.
Download (505kB) | Preview
Official URL: https://doi.org/10.1016/j.ymthe.2024.06.008
Abstract
Sepsis is a complex condition leading to multiple organ failure including the development of acute respiratory distress syndrome
(ARDS) secondary to infection. The mortality rate of sepsis is 40%–60%,1 indicating an
unmet need for the development of novel
therapeutics for this condition. Mesenchymal stromal cells (MSCs) are known for
their immunomodulatory and cytoprotective
effects; however, their efficacy as a cellular
therapy for sepsis has been disappointing,
with less than �50% of patients responding
to treatment. Thus, strategies to enhance
MSC efficacy to increase the response rates
in patients are eagerly awaited.
| Item Type: | Article |
|---|---|
| Keywords: | Carbon monoxide licensing; MSCs enhances; autophagy-mediated miRNA mechanisms; |
| Academic Unit: | Faculty of Science and Engineering > Biology |
| Item ID: | 18682 |
| Identification Number: | 10.1016/j.ymthe.2024.06.008 |
| Depositing User: | Karen English |
| Date Deposited: | 21 Jun 2024 09:12 |
| Journal or Publication Title: | Molecular Therapy |
| Publisher: | Elsevier |
| Refereed: | Yes |
| Related URLs: | |
| Use Licence: | This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here |
Downloads
Downloads per month over past year
Share and Export
Share and Export